Yoshimi Nozu

1.1k citations
21 papers · 600 indexed · h-index 14
Topics
Renal and related cancers (7 papers)Ion Transport and Channel Regulation (7 papers)Cell Adhesion Molecules Research (7 papers)
Partner nations
JapanUnited Kingdom

In The Last Decade

Yoshimi Nozu

21 papers receiving 593 citations

Peers

Yoshimi Nozu
Comparison fields: 5 of 56
  • Molecular Biology 412
  • Immunology and Allergy 227
  • Nephrology 156
  • Genetics 146
  • Hematology 84
Replace Naoya Morisada with:
Naoya Morisada Japan
Alison Homstad United States
Nanami Gotoh Japan
Britta George Germany
Harald O. Schöcklmann Germany
Rita Foti Australia
Jiamin Teng United States
Purba Biswas United States
Mohamed H. Al‐Hamed Saudi Arabia
Shoichiro Kanda Japan
Yoshimi Nozu relative to Naoya Morisada Japan Naoya Morisada's profile →
Citations per field
00.5×1.5×1.8×
Naoya Morisada · 1×
Citations per year

Countries citing papers authored by Yoshimi Nozu

Since Specialization
Citations

This map shows the geographic impact of Yoshimi Nozu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Nozu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Nozu more than expected).

Fields of papers citing papers by Yoshimi Nozu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Nozu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Nozu. The network helps show where Yoshimi Nozu may publish in the future.

Co-authorship network of co-authors of Yoshimi Nozu

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Nozu. A scholar is included among the top collaborators of Yoshimi Nozu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Nozu. Yoshimi Nozu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 63
2 9
3 37
4 21
5 10
6 6
7 59
8 4
9 11
10 16
11 84
12 56
13 14
14 8
15 28
16 25
17 32
18 22
19 71
20 3

About Yoshimi Nozu

Yoshimi Nozu is a scholar working on Immunology and Allergy, Nephrology and Hematology, having authored 21 papers that have together received 600 indexed citations. Recurring topics across this work include Renal and related cancers (7 papers), Ion Transport and Channel Regulation (7 papers) and Cell Adhesion Molecules Research (7 papers). The work is most often cited by research in Immunology and Allergy (227 citations), Nephrology (156 citations) and Hematology (84 citations). Yoshimi Nozu has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Kandai Nozu, Kazumoto Iijima, Koichi Nakanishi, Hiroshi Kaito, Xue Jun Fu, Tomohiko Yamamura, Norishige Yoshikawa, Shogo Minamikawa, Takeshi Ninchoji and Yuko Shima. Their work appears in journals such as PEDIATRICS, Kidney International and Clinical Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026